Hints and tips:
...As Greenwald has not travelled to the US since the Snowden story broke, Shawn came to Rio to put on a performance for him....
...Shawn Manning, an analyst at Singer Capital Markets, said that approval in Europe was likely to “get things moving again” with the US Food and Drug Administration....
...“Given that both parties have expressed an interest, and given our view that 130p is a bargain price, we would not be entirely surprised should a higher bid be tendered,” said Singer analyst Shawn Manning...
...But Shawn Manning, an analyst with Singer Capital Markets, pointed out that these “irrevocable” undertakings only cover bids up to 139p, so a counter-bid of 140p could be accepted....
...“The UK currently constitutes a ‘heady environment’ for this sort of activity,” wrote Shawn Manning, an analyst at Singer. In the past, many UK investors have shied away from drug research companies....
...“It hasn’t been great, but then I’d argue that it hasn’t been terribly bad either,” says Shawn Manning, a biotech analyst at Singer Capital, of the recent investment climate....
...Shawn Manning, an analyst at Landsbanki Securities, said Dr Cunningham was “an excellent choice” as chief executive....
...Shawn Manning, an analyst at Landsbanki, said: “Given that the longer-term value of revenues fromFrovatriptan in Europe exceeds €18.4m, we imagine that the UK company has set a limit on its payments to Paul...
...Shawn Manning, analyst at Landsbanki, was positive about SkyePharma’s prospects, however. “Taking cash from the company when it hasn’t got any products or waiting until Flutiform is on the market?...
...Shawn Manning, analyst at Landsbanki, said: “The changes will effectively reposition Vernalis as a purely research-based biotech company.” Simon Sturge, chief executive, will step down this month....
...Shawn Manning, analyst at Landsbanki, said: “This is positive news, both in terms of a credible partner, and timing....
...The original Napster worked like a telephone operator manning a vast switchboard....
...Shawn Manning at Dresdner Kleinwort Wasserstein said that speciality healthcare groups, which sell niche products, attracted higher multiples in the US than in Europe....
International Edition